<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04048798</url>
  </required_header>
  <id_info>
    <org_study_id>88298</org_study_id>
    <nct_id>NCT04048798</nct_id>
  </id_info>
  <brief_title>Nasal High Flow in Bariatric Surgery</brief_title>
  <official_title>Effect of Nasal High Flow on Perioperative Oxygenation in Patients Undergoing Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      High frequency nasal cannula (HFNC) provides an inspiration O2 fraction of 21-1% and it has a
      minimal dead space and can be well tolerated due to humidified air. Group I patients will be
      applied HFNC before and after bariatric surgery, Group II patients will be applied a constant
      O2 concentration via face mask. Oxygen pressure, oxygen saturation, carbon dioxide,
      respiration frequency, forced vital capacity will be measured before and after surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Morbid obese patients are prone to atelectasis and hypoxemia after bariatric surgery. High
      frequency nasal cannula (HFNC) provides an inspiration O2 fraction of 21-1% and it has a
      minimal dead space and can be well tolerated due to humidified air. It provides 5-7 cm H2O
      positive end expiratory pressure to the airways and may prevent atelectasis. In the
      preoperative room, forced vital capacity, peripheral oxygen saturation (SpO2), respiratory
      frequency, heart rate (HR), blood pressure (BP), carbon dioxide, oxygen pressure and carbon
      dioxide partial pressure values in blood gas analysis will be recorded. We will apply HFNC in
      the preoperative and postoperative period to Group I patients, while applying a constant O2
      concentration to Group II patients. After appliying HFNC for two hours in Group I patients
      and O2 via face mask in Group II patients measurements will be repeated. During surgery,
      similar mechanical ventilation parameters will be applied to the patients. After the
      operation Group I patients will be applied HFNC, while Group II patients will be applied O2
      via face mask in the recovery room for two hours. Measurements will be repeated. Primary end
      point of the study is the association between oxygen pressure, carbon dioxide partial
      pressure values among preoperative before and after HFNC and O2 and postoperative times.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PO2 value</measure>
    <time_frame>24 hours</time_frame>
    <description>PO2 value will be measured before HFNC or face mask, after HFNC or face mask and after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PCO2 value</measure>
    <time_frame>24 hours</time_frame>
    <description>PO2 value will be measured before HFNC or face mask, after HFNC or face mask and after surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>Oxygen therapy via HFNC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who will be applied high frequency nasal cannula before and after surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxygen therapy via face mask</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who will be applied O2 via face mask before and after surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oxygen therapy via HFNC</intervention_name>
    <description>Oxygen treatment will be applied to the patients via HFNC before and after surgery</description>
    <arm_group_label>Oxygen therapy via HFNC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oxygen therapy via face mask</intervention_name>
    <description>Oxygen treatment will be applied to the patients via face mask before and after surgery</description>
    <arm_group_label>Oxygen therapy via face mask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a body mass index of 40-55 kg/m2

          -  American Society of Anesthesiologists score II-III

          -  Patients undergoing laparoscopic sleeve gastrectomy or one anastomosis gastric bypass

        Exclusion Criteria:

          -  Obstructive sleep apnea syndrome

          -  Using a non invasive mechanical ventilation device preoperatively

          -  Patients whoo will predicted to postanesthesia care unit admission postoperatively
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cigdem A BEYOGLU</last_name>
    <role>Principal Investigator</role>
    <affiliation>İstanbul Üniversitesi- Cerrahpaşa Cerrahpaşa Tıp Fakültesi</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cigdem A BEYOGLU</last_name>
    <phone>+905052278176</phone>
    <email>akyolbeyoglu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guniz Koksal</last_name>
    <phone>05424138505</phone>
    <email>gunizkoksal@hotmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Baraka AS, Taha SK, Siddik-Sayyid SM, Kanazi GE, El-Khatib MF, Dagher CM, Chehade JM, Abdallah FW, Hajj RE. Supplementation of pre-oxygenation in morbidly obese patients using nasopharyngeal oxygen insufflation. Anaesthesia. 2007 Aug;62(8):769-73.</citation>
    <PMID>17635423</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 2, 2019</study_first_submitted>
  <study_first_submitted_qc>August 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2019</study_first_posted>
  <last_update_submitted>August 6, 2019</last_update_submitted>
  <last_update_submitted_qc>August 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Dr Cigdem Akyol Beyoğlu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>morbid obesity</keyword>
  <keyword>bariatric surgery</keyword>
  <keyword>high frequency nasal cannula</keyword>
  <keyword>oxygenation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>I am unaware of the advantages or disadvantages of sharing IPD</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

